Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01133847 · ClinicalTrials.gov registry record · Phase 4
Interventions for Children With Attention and Reading Disorders
A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 4
- Development phase
- 222
- Enrollment target
NCT01133847 is a Phase 4 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 222 participants.
The verdict
NCT01133847, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 222 participants
- Enrollment target
Study Summary
The objective of this randomized clinical trial is to address unanswered questions about the relative effectiveness of treatments for children with both Attention Deficit Hyperactivity Disorder (ADHD) and significant reading difficulties (RD). The study evaluates attentional and word reading outcomes for students with both conditions when provided with either (a) ADHD treatment alone, (b) RD treatment alone, or (c) the combination of ADHD and RD treatment.
Interventions
- DRUG Methylphenidate
- DRUG Atomoxetine
- BEHAVIORAL Parent Training
- BEHAVIORAL Intensive reading instruction
- DRUG Mixed Salt Amphetamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 222 participants |
| Start Date | 2010-11 |
| Est. Completion | 2015-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01133847
The ClinicalTrials.gov registry entry for NCT01133847 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 222 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Methylphenidate is the first listed.
NCT01133847 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01133847 about?
NCT01133847 is a clinical study titled "Interventions for Children With Attention and Reading Disorders". The objective of this randomized clinical trial is to address unanswered questions about the relative effectiveness of treatments for children with both Attention Deficit Hyperactivity Disorder (ADHD) and significant reading difficulties (RD). The study evaluates attentional and word reading outcome...
What is the current status of trial NCT01133847?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 222 participants. The study started on 2010-11. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01133847?
The interventions under investigation include: Methylphenidate (DRUG), Atomoxetine (DRUG), Parent Training (BEHAVIORAL), Intensive reading instruction (BEHAVIORAL), Mixed Salt Amphetamine (DRUG).
Who is sponsoring clinical trial NCT01133847?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.